Literature DB >> 33815654

Bu Shen Yi Sui Capsule Alleviates Neuroinflammation and Demyelination by Promoting Microglia toward M2 Polarization, Which Correlates with Changes in miR-124 and miR-155 in Experimental Autoimmune Encephalomyelitis.

Zheng Zha1, Yan-Fang Gao1, Jing Ji1, Ya-Qin Sun1, Jun-Ling Li1, Fang Qi1, Nan Zhang1, Liang-Yun Jin2, Bing Xue2, Tao Yang3, Yong-Ping Fan3, Hui Zhao1, Lei Wang1.   

Abstract

BACKGROUND: Bu Shen Yi Sui capsule (BSYS) is a traditional Chinese medicine prescription that has shown antineuroinflammatory and neuroprotective effects in treating multiple sclerosis (MS) and its animal model of experimental autoimmune encephalomyelitis (EAE). Microglia play an important role in neuroinflammation. The M1 phenotype of microglia is involved in the proinflammatory process of the disease, while the M2 phenotype plays an anti-inflammatory role. Promoting the polarization of microglia to M2 in MS/EAE is a promising therapeutic strategy. This study is aimed at exploring the effects of BSYS on microglial polarization in mice with EAE.
METHODS: The EAE model was established by the intraperitoneal injection of pertussis toxin and subcutaneous injection of myelin oligodendrocyte glycoprotein (MOG)35-55 in C57BL/6J mice. The mice were treated with BSYS (3.02 g/kg), FTY720 (0.3 mg/kg), or distilled water by intragastric administration. H&E and LFB staining, transmission electron microscopy, qRT-PCR, immunofluorescence, ELISA, fluorescence in situ hybridization, and western blotting were used to detect the histological changes in myelin, microglial M1/M2 polarization markers, and the expression of key genes involved in EAE. Results and Conclusions. BSYS treatment of EAE mice increased the body weight, decreased the clinical score, and reduced demyelination induced by inflammatory infiltration. BSYS also inhibited the mRNA expression of M1 microglial markers while increasing the mRNA level of M2 markers. Additionally, BSYS led to a marked decrease in the ratio of M1 microglia (iNOS+/Iba1+) and an obvious increase in the number of M2 microglia (Arg1+/Iba1+). In the EAE mouse model, miR-124 expression was decreased, and miR-155 expression was increased, while BSYS treatment significantly reversed this effect and modulated the levels of C/EBP α, PU.1, and SOCS1 (target genes of miR-124 and miR-155). Therefore, the neuroprotective effect of BSYS against MS/EAE was related to promoting microglia toward M2 polarization, which may be correlated with changes in miR-124 and miR-155 in vivo.
Copyright © 2021 Zheng Zha et al.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33815654      PMCID: PMC7987454          DOI: 10.1155/2021/5521503

Source DB:  PubMed          Journal:  Oxid Med Cell Longev        ISSN: 1942-0994            Impact factor:   6.543


  71 in total

Review 1.  Traditional Chinese Medicine for Alzheimer's Disease and Other Cognitive Impairment: A Review.

Authors:  Hui Pei; Lina Ma; Yu Cao; Feixue Wang; Zehui Li; Nanyang Liu; Meixia Liu; Yun Wei; Hao Li
Journal:  Am J Chin Med       Date:  2020-04-24       Impact factor: 4.667

Review 2.  Alternatively activated microglia and macrophages in the central nervous system.

Authors:  Rafael Franco; Diana Fernández-Suárez
Journal:  Prog Neurobiol       Date:  2015-06-08       Impact factor: 11.685

Review 3.  Macrophages and CNS remyelination.

Authors:  Veronique E Miron; Robin J M Franklin
Journal:  J Neurochem       Date:  2014-03-26       Impact factor: 5.372

Review 4.  Role of Microglia in Neurological Disorders and Their Potentials as a Therapeutic Target.

Authors:  Li Du; Ying Zhang; Yang Chen; Jie Zhu; Yi Yang; Hong-Liang Zhang
Journal:  Mol Neurobiol       Date:  2016-11-09       Impact factor: 5.590

5.  Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-beta 2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system.

Authors:  Guang-Xian Zhang; Bruno Gran; Shuo Yu; Jifen Li; Ines Siglienti; Xiaohan Chen; Malek Kamoun; Abdolmohamad Rostami
Journal:  J Immunol       Date:  2003-02-15       Impact factor: 5.422

6.  Suppression of miR-155 attenuates neuropathic pain by inducing an M1 to M2 switch in microglia.

Authors:  Yanxiang Zhang; Qi Chen; Yu Nai; Chunni Cao
Journal:  Folia Neuropathol       Date:  2020       Impact factor: 2.038

7.  Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet Neurol       Date:  2019-03-14       Impact factor: 44.182

8.  Suppressor of cytokine signaling (SOCS)1 is a key determinant of differential macrophage activation and function.

Authors:  Claire S Whyte; Eileen T Bishop; Dominik Rückerl; Silvia Gaspar-Pereira; Robert N Barker; Judith E Allen; Andrew J Rees; Heather M Wilson
Journal:  J Leukoc Biol       Date:  2011-05-31       Impact factor: 4.962

9.  The miRNA Expression Profile of Experimental Autoimmune Encephalomyelitis Reveals Novel Potential Disease Biomarkers.

Authors:  Shivaprasad H Venkatesha; Steven Dudics; Yang Song; Anup Mahurkar; Kamal D Moudgil
Journal:  Int J Mol Sci       Date:  2018-12-11       Impact factor: 5.923

Review 10.  MicroRNAs as disease progression biomarkers and therapeutic targets in experimental autoimmune encephalomyelitis model of multiple sclerosis.

Authors:  Bridget Martinez; Philip V Peplow
Journal:  Neural Regen Res       Date:  2020-10       Impact factor: 5.135

View more
  6 in total

1.  Microglia Polarization from M1 toward M2 Phenotype Is Promoted by Astragalus Polysaccharides Mediated through Inhibition of miR-155 in Experimental Autoimmune Encephalomyelitis.

Authors:  Xiaojun Liu; Jinyun Ma; Guiqing Ding; Qianyi Gong; Yuanhua Wang; Hua Yu; Xiaodong Cheng
Journal:  Oxid Med Cell Longev       Date:  2021-12-24       Impact factor: 6.543

2.  MicroRNA-124 Alleviates Retinal Vasoregression via Regulating Microglial Polarization.

Authors:  Ying Chen; Jihong Lin; Andrea Schlotterer; Luke Kurowski; Sigrid Hoffmann; Seddik Hammad; Steven Dooley; Malte Buchholz; Jiong Hu; Ingrid Fleming; Hans-Peter Hammes
Journal:  Int J Mol Sci       Date:  2021-10-14       Impact factor: 5.923

Review 3.  Microglia Polarization: A Novel Target of Exosome for Stroke Treatment.

Authors:  Teng Wan; Yunling Huang; Xiaoyu Gao; Wanpeng Wu; Weiming Guo
Journal:  Front Cell Dev Biol       Date:  2022-03-09

4.  Study on the Anti-demyelination Mechanism of Bu-Shen-Yi-Sui Capsule in the Central Nervous System Based on Network Pharmacology and Experimental Verification.

Authors:  Zheng Zha; Yi-Jiang Liu; Si-Si Liu; Nan Zhang; Jun-Ling Li; Fang Qi; Liang-Yun Jin; Bing Xue; Tao Yang; Yong-Ping Fan; Hui Zhao; Lei Wang
Journal:  Mediators Inflamm       Date:  2022-07-12       Impact factor: 4.529

Review 5.  Exosomes: A novel insight into traditional Chinese medicine.

Authors:  Chao Mo; Jie Zhao; Jingyan Liang; Huiling Wang; Yu Chen; Guodong Huang
Journal:  Front Pharmacol       Date:  2022-08-29       Impact factor: 5.988

6.  Bu Shen Yi Sui Capsule Promotes Myelin Repair by Modulating the Transformation of A1/A2 Reactive Astrocytes In Vivo and In Vitro.

Authors:  Zheng Zha; Yi-Jiang Liu; Si-Si Liu; Nan Zhang; Jun-Ling Li; Fang Qi; Liang-Yun Jin; Bing Xue; Tao Yang; Yong-Ping Fan; Hui Zhao; Lei Wang
Journal:  Oxid Med Cell Longev       Date:  2022-09-01       Impact factor: 7.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.